Age Related Cataracts

4

Review clinical trials related to Age Related Cataracts. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Intraindividual Comparison of EMO IOLs

The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.

Participants needed: 461
Trial details
Age: 50-100Biological sex: AllType: InterventionalSponsor: Medical University of ViennaUpdated: Dec 5, 2025Locations: 1
Eligibility criteria

Bilateral age-related cataract planned for phacoemulsification extraction and po... [+6]

Preceding intraocular surgery or ocular trauma [+6]

Status: Recruiting

Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens

This is a two-part, multi-center, investigator-initiated clinical study comparing visual outcomes and patient satisfaction in subjects receiving bilateral implantation of either the Clareon PanOptix intraocular lens (IOL) or a comparable multifocal IOL. The study includes a retrospective/prospective pilot phase and a prospective, randomized comparison phase.

Participants needed: 290
Trial details
Biological sex: AllType: InterventionalSponsor: Argus Research Center, Inc.Updated: Jun 5, 2025Locations: 3
Eligibility criteria

Willing and able to understand and sign informed consent. [+10]

Corneal pathology, irregular astigmatism, preexisting macular disease and other... [+13]

Status: Recruiting

Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric & PODEYE Toric

The investigational devices are approved intraocular lenses (IOL) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Within the study, three different IOLs will be investigated and separately evaluated. Cataract surgery with IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be postoperative refraction, visual acuity, slitlamp examination, and rotation of the IOL within 1 hour, 1 week, 1 month and 4-7 months. In the Alcon Clareon toric, RayOne EMV toric and PODEYE Toric group, patients receive a toric IOL according to their preoperative astigmatism

Participants needed: 750
Trial details
Age: 45-95Biological sex: AllType: InterventionalSponsor: Medical University of ViennaUpdated: May 14, 2025Locations: 1
Eligibility criteria

Uni- or bilateral age-related cataract necessitating phacoemulsification extract... [+7]

Preceding ocular surgery or trauma [+12]

Status: Recruiting

Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome

The aim of this study is to compare the surgical outcomes of the two IOL implantation methods for eyes with cataract and PEX in a single-center and with highly experienced surgeons. The goal is to acquire relevant information regarding these two IOL implantation techniques, which will help surgeons to decide which approach to choose, ultimately resulting in a benefit for patients with PEX syndrome who require cataract surgery. The main questions are: Is there a difference in lens tilt and decentration between the both methods. Is there a difference in the frequency and amount of capsular phimosis between the both methods.

Participants needed: 120
Trial details
Age: 60-100Biological sex: AllType: InterventionalSponsor: Medical University of ViennaUpdated: Oct 24, 2023Locations: 1
Eligibility criteria

Age 60 - 100 [+2]

Endstage glaucoma [+2]